These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Amino-terminal brain natriuretic peptide is related to the presence of diabetic polyneuropathy independently of cardiovascular disease. Jurado J; Ybarra J; Ferrandiz M; Comerma L; Pou JM Diabetes Care; 2007 Aug; 30(8):e86. PubMed ID: 17855271 [No Abstract] [Full Text] [Related]
8. B-type natriuretic peptide: where are we? Nozzoli C Ann Ital Med Int; 2005; 20(3):II-III. PubMed ID: 16250179 [No Abstract] [Full Text] [Related]
9. [Health-related reference intervals for B-type natriuretic peptides. The suitability for decision limits in outpatient care is still not clear]. Lindstedt G; Tryding N Lakartidningen; 2007 Jul 11-24; 104(28-29):2071-5. PubMed ID: 17702380 [No Abstract] [Full Text] [Related]
10. B-type natriuretic peptide and the stressed heart. Nohria A; Givertz MM J Am Coll Cardiol; 2006 Feb; 47(4):749-51. PubMed ID: 16487839 [No Abstract] [Full Text] [Related]
11. The challenges of properly identifying the cause of heart failure hospitalization. Ghali JK Arch Intern Med; 2010 Jul; 170(14):1274-5; author reply 1275. PubMed ID: 20660852 [No Abstract] [Full Text] [Related]
12. The role of b-type natriuretic peptide in heart failure management. Newton PJ; Betihavas V; Macdonald P Aust Crit Care; 2009 Aug; 22(3):117-23. PubMed ID: 19589695 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study). O'Donoghue M; Kenney P; Oestreicher E; Anwaruddin S; Baggish AL; Krauser DG; Chen A; Tung R; Cameron R; Januzzi JL Am J Cardiol; 2007 Nov; 100(9):1336-40. PubMed ID: 17950786 [TBL] [Abstract][Full Text] [Related]
15. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure. Tang WH; Francis GS; Morrow DA; Newby LK; Cannon CP; Jesse RL; Storrow AB; Christenson RH; Clin Biochem; 2008 Mar; 41(4-5):210-21. PubMed ID: 18048022 [No Abstract] [Full Text] [Related]
16. B-type natriuretic peptide-a CPK for heart-failure and beyond (ischemia)? Arora V; Bhandari S Indian Heart J; 2006; 58(2):90-2. PubMed ID: 18989049 [No Abstract] [Full Text] [Related]
17. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088 [TBL] [Abstract][Full Text] [Related]
18. The use of B-type natriuretic peptide in paediatric patients: a review of literature. Favilli S; Frenos S; Lasagni D; Frenos F; Pollini I; Bernini G; Aricò M; Bini RM J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):298-302. PubMed ID: 19430339 [TBL] [Abstract][Full Text] [Related]
19. Biomarkers in heart failure. Does prognostic utility translate to clinical futility? Maisel A J Am Coll Cardiol; 2007 Sep; 50(11):1061-3. PubMed ID: 17825715 [No Abstract] [Full Text] [Related]
20. Diagnosing acute heart failure: the mathematician and the clinician. Dickstein K J Am Coll Cardiol; 2009 Oct; 54(16):1522-3. PubMed ID: 19815123 [No Abstract] [Full Text] [Related] [Next] [New Search]